Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,005.84 +927.46 (+1.38%) CMC Crypto 200
1,378.91 +48.31 (+3.63%)
Danimer Scientific, Inc. (DNMR)
After hours:
| Previous close | 0.5317 |
| Open | 0.5385 |
| Bid | 0.5160 x 800 |
| Ask | 0.5500 x 800 |
| Day's range | 0.5120 - 0.5469 |
| 52-week range | 0.5120 - 2.8300 |
| Volume | |
| Avg. volume | 890,524 |
| Market cap | 61.353M |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4200 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.41 |
- Business Wire
Danimer Scientific Completes Dividend Distribution of Warrants to Stockholders
BAINBRIDGE, Ga., July 12, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants ("Dividend Warrants") to holders of the Company’s Class A Common Stock, par value $0.0001 per share ("Common Stock"), as of May 13, 2024 ("Record Date"). The stockholders of rec
- Business Wire
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
BAINBRIDGE, Ga., May 24, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, announced that it received a notice from the New York Stock Exchange ("NYSE") on May 21, 2024, that the Company is not currently in compliance with the NYSE’s continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a period
- Business Wire
Danimer Scientific Announces Steve Croskrey Retirement and Related Changes to the Company’s Board of Directors
BAINBRIDGE, Ga., May 20, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year. Mr. Croskrey’s employment contract expires at the end of 2024 following nine years leading Danimer’s mission to com
